TELA Bio, Inc.

NasdaqGM TELA

TELA Bio, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -45.62 M

TELA Bio, Inc. Operating Income is USD -45.62 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -10.63% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • TELA Bio, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -41.24 M, a -10.78% change year over year.
  • TELA Bio, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -37.22 M, a -30.40% change year over year.
  • TELA Bio, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -28.54 M, a -17.20% change year over year.
  • TELA Bio, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -24.35 M, a -29.31% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
NasdaqGM: TELA

TELA Bio, Inc.

CEO Mr. Antony Koblish
IPO Date Nov. 8, 2019
Location United States
Headquarters 1 Great Valley Parkway
Employees 227
Sector Health Care
Industries
Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Similar companies

VREX

Varex Imaging Corporation

USD 13.52

1.05%

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

CVRX

CVRx, Inc.

USD 16.15

7.38%

DCTH

Delcath Systems, Inc.

USD 12.69

-0.78%

SIBN

SI-BONE, Inc.

USD 15.70

-3.27%

TCMD

Tactile Systems Technology, Inc.

USD 17.46

1.51%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

CLPT

ClearPoint Neuro, Inc.

USD 14.70

-4.54%

StockViz Staff

January 15, 2025

Any question? Send us an email